These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34150848)

  • 1. Sex-Related Overactivation of NLRP3 Inflammasome Increases Lethality of the Male COVID-19 Patients.
    Zhang H; Tang Y; Tao J
    Front Mol Biosci; 2021; 8():671363. PubMed ID: 34150848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.
    Dutta D; Liu J; Xiong H
    Int J Physiol Pathophysiol Pharmacol; 2022; 14(3):138-160. PubMed ID: 35891930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.
    Zhao N; Di B; Xu LL
    Cytokine Growth Factor Rev; 2021 Oct; 61():2-15. PubMed ID: 34183243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer.
    Batiha GE; Al-Gareeb AI; Rotimi D; Adeyemi OS; Al-Kuraishy HM
    Sci Afr; 2022 Nov; 18():e01407. PubMed ID: 36310607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of NLRP3 Inflammasome in SARS-Cov-2-Induced Multiorgan Dysfunction in Patients with COVID-19: A Review of Molecular Mechanisms.
    Babazadeh Z
    Tanaffos; 2023 Jan; 22(1):40-52. PubMed ID: 37920322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention.
    Zhang J; Ma X; Liu F; Zhang D; Ling J; Zhu Z; Chen Y; Yang P; Yang Y; Liu X; Zhang J; Liu J; Yu P
    Front Immunol; 2023; 14():1203389. PubMed ID: 37868953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.
    Yong YY; Zhang L; Hu YJ; Wu JM; Yan L; Pan YR; Tang Y; Yu L; Law BY; Yu CL; Zhou J; Li M; Qin DL; Zhou XG; Wu AG
    Clin Immunol; 2022 Nov; 244():109093. PubMed ID: 35944881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
    Lécuyer D; Nardacci R; Tannous D; Gutierrez-Mateyron E; Deva Nathan A; Subra F; Di Primio C; Quaranta P; Petit V; Richetta C; Mostefa-Kara A; Del Nonno F; Falasca L; Marlin R; Maisonnasse P; Delahousse J; Pascaud J; Deprez E; Naigeon M; Chaput N; Paci A; Saada V; Ghez D; Mariette X; Costa M; Pistello M; Allouch A; Delelis O; Piacentini M; Le Grand R; Perfettini JL
    Front Immunol; 2023; 14():1270081. PubMed ID: 37920468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein.
    Albornoz EA; Amarilla AA; Modhiran N; Parker S; Li XX; Wijesundara DK; Aguado J; Zamora AP; McMillan CLD; Liang B; Peng NYG; Sng JDJ; Saima FT; Fung JN; Lee JD; Paramitha D; Parry R; Avumegah MS; Isaacs A; Lo MW; Miranda-Chacon Z; Bradshaw D; Salinas-Rebolledo C; Rajapakse NW; Wolvetang EJ; Munro TP; Rojas-Fernandez A; Young PR; Stacey KJ; Khromykh AA; Chappell KJ; Watterson D; Woodruff TM
    Mol Psychiatry; 2023 Jul; 28(7):2878-2893. PubMed ID: 36316366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity.
    Amin S; Aktar S; Rahman MM; Chowdhury MMH
    Microbes Infect; 2022 Feb; 24(1):104913. PubMed ID: 34838941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 nucleocapsid protein promotes TMAO-induced NLRP3 inflammasome activation by SCAP-SREBP signaling pathway.
    Liu MH; Lin XL; Xiao LL
    Tissue Cell; 2024 Feb; 86():102276. PubMed ID: 37979395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the NLRP3 inflammasome by Sars-CoV-2 Envelope protein.
    Yalcinkaya M; Liu W; Islam MN; Kotini AG; Gusarova GA; Fidler TP; Papapetrou EP; Bhattacharya J; Wang N; Tall AR
    Sci Rep; 2021 Dec; 11(1):24432. PubMed ID: 34952919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
    Sur S; Steele R; Isbell TS; Ray R; Ray RB
    mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescuing fertility during COVID-19 infection: exploring potential pharmacological and natural therapeutic approaches for comorbidity, by focusing on NLRP3 inflammasome mechanism.
    Hosseini E; Kohan-Ghadr HR; Bazrafkan M; Amorim CA; Askari M; Zakeri A; Mousavi SN; Kafaeinezhad R; Afradiasbagharani P; Esfandyari S; Nazari M
    J Assist Reprod Genet; 2023 May; 40(5):1173-1185. PubMed ID: 36892705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NLRP3 inflammasome in COVID-19 and periodontitis: Possible protective effect of melatonin.
    Şehirli AÖ; Aksoy U; Koca-Ünsal RB; Sayıner S
    Med Hypotheses; 2021 Jun; 151():110588. PubMed ID: 33848919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in Elderly Patients.
    Lara PC; Macías-Verde D; Burgos-Burgos J
    Aging Dis; 2020 Jul; 11(4):756-762. PubMed ID: 32765942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation.
    Pan P; Shen M; Yu Z; Ge W; Chen K; Tian M; Xiao F; Wang Z; Wang J; Jia Y; Wang W; Wan P; Zhang J; Chen W; Lei Z; Chen X; Luo Z; Zhang Q; Xu M; Li G; Li Y; Wu J
    Nat Commun; 2021 Aug; 12(1):4664. PubMed ID: 34341353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation.
    Rodrigues TS; Zamboni DS
    Curr Opin Immunol; 2023 Oct; 84():102387. PubMed ID: 37703588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, Brazil.
    de Sá NBR; Neira-Goulart M; Ribeiro-Alves M; Perazzo H; Geraldo KM; Ribeiro MPD; Cardoso SW; Grinsztejn B; Veloso VG; Capão A; Siqueira MM; de Lima Bezerra OC; Garcia CC; Gomes LR; da Silva Cazote A; de Almeida DV; Giacoia-Gripp CBW; Côrtes FH; Morgado MG
    Biomed Res Int; 2022; 2022():9082455. PubMed ID: 36105941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.